search
Back to results

Randomized Controlled Trial Intervention With New Nordic DIet in Women With GestatiOnal Diabetes Mellitus: iNDIGO (iNDIGO)

Primary Purpose

Gestational Diabetes Mellitus

Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
New Nordic Diet
Control
Sponsored by
Göteborg University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gestational Diabetes Mellitus

Eligibility Criteria

18 Years - 50 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • pregnant women with diagnosis of gestational diabetes in pregnancy wks 24-28.

Exclusion Criteria:

  • multiple pregnancies
  • not understanding/able to read Swedish
  • unwilling to follow a dietary intervention
  • manifest diabetes

Sites / Locations

  • Antenatal careRecruiting
  • Region StockholmRecruiting
  • Region VästerbottenRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention

Control

Arm Description

Women randomized to the New Nordic Diet meet the study dietician at week 30 for 1.5 hr of individual diet treatment according to the New Nordic Diet and a cognitive behavioral approach. The diet advice include evenly distributed meals over the day, foods low in fat and rich in fibre, 500 g fruit and vegetables daily, fish 2-3 times a week and keyhole foods. Participants will prepare their own food but are provided with recipes and food bags containing ingredients and foods to be consumed during the two-week intervention At gestational age 32 weeks, women meet with a dietitian and will be instructed to continue with the New Nordic Diet diet throughout pregnancy on their own.

The control women receive diet advice according to usual care.

Outcomes

Primary Outcome Measures

Time in Target at gestational week 32
Percentage of time in target (TIT) range 3.5-7.8 mmol/L measured with continuous glucose monitoring

Secondary Outcome Measures

Pregnancy weight gain
Weight gain during pregnancy from self-reported pre-pregnancy weight until delivery
Incidence of pregnancy-induced hypertension
Diagnosis of pregnancy-induced hypertension
Incidence of pre-eclampsia
Diagnosis of pre-eclampsia
Prevalence of use of insulin/Metformin treatment
Decision to put woman on medication for the gestational diabetes, such as metformin or insulin
Incidence of preterm delivery
Delivery before 37 completed weeks
Incidence of Caesarean sections
Delivery by caesarean sections
Health-related quality of life
Health-related quality of life, calculated from questionnaire information from RAND-36
Incidence of LGA
Large-for-gestational age born infant
Incidence of shoulder displacement
Shoulder displacement of newborn infant
Apgar scores measurements
Apgar scores measured at 1, 5 and 10 minutes after delivery
Additional measurements from continuous glucose monitoring at wk 32
mean glucose, CV, SD, MAGE, % time with values >7.8 mmol/L, % time with values <3.5 mmol/L, glucose in different time periods, and AUC
Additional measurements from continuous glucose monitoring at wk 36
mean glucose, CV, SD, MAGE, % time with values >7.8 mmol/L, % time with values <3.5 mmol/L, glucose in different time periods, and AUC
Incidence of macrosomia
Diagnosis of macrosomia in newborn infant
Nutritional status
Nutritional status (vitamins and minerals) of mother during pregnancy
Diet quality measuremen¨t
Diet intake quality of mother during pregnancy

Full Information

First Posted
October 28, 2019
Last Updated
August 24, 2023
Sponsor
Göteborg University
Collaborators
Swedish Council for Working Life and Social Research
search

1. Study Identification

Unique Protocol Identification Number
NCT04169243
Brief Title
Randomized Controlled Trial Intervention With New Nordic DIet in Women With GestatiOnal Diabetes Mellitus: iNDIGO
Acronym
iNDIGO
Official Title
Randomized Controlled Trial Intervention With New Nordic DIet in Women With GestatiOnal Diabetes Mellitus: iNDIGO
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 1, 2022 (Actual)
Primary Completion Date
December 2024 (Anticipated)
Study Completion Date
December 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Göteborg University
Collaborators
Swedish Council for Working Life and Social Research

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study evaluates whether the New Nordic Diet, compared to routine care, will improve glucose control, among women developing gestational diabetes mellitus during pregnancy. Originally, a 10 wk intervention with qualified counseling on New Nordic Diet was planned, and effects on glycosylated haemoglobin A (HbA1c) at gestational age 37 weeks was planned as main outcome. Recruitment started in spring 2020 but had to be halted due to covid-19. Instead, we now conduct a more comprehensive version of the study, with a more intensive intervention consisting of distributed food bags plus dietary counselling for two weeks, and with continuous glucose monitoring during these two weeks to measure main outcome. This is more sensitive to small changes than is HbA1c. With this shorter and more intensive intervention we believe we can address our original hypothesis yet adjust to impacts of the covid-19 situation on the population and health care system.
Detailed Description
Gestational diabetes mellitus (GDM) is associated with severe adverse outcomes for mother and newborn. Recently introduced Swedish guidelines on GDM diagnosis will at least double the prevalence of diagnosed women. The first line of treatment in GDM is diet and exercise treatment. Even so, there is a recognized knowledge gap as to what diet treatment is optimal. In routine care today, diagnosed women are provided by midwife with the same diet advice as patients with diabetes type 2 and these are broad and general. Only rarely are the diet advice provided by a dietician. In nutrition research, most evidence for health benefits of a diet has been demonstrated for the Mediterranean diet. Further, the New Nordic Diet (NND) was recently developed to mimic the Mediterranean diet yet builds on foods grown in the Nordic climate, thus focusing on gastronomical potential and sustainability. Interestingly, a diet intake in line with NND among Norwegian mothers was associated with lower risk for excessive pregnancy weight gain. In addition, associations have been shown between NND and lower risk for cardiovascular disease, obesity, inflammatory risk markers, serum lipids, colorectal cancer and total mortality. Hence, it seems likely that diet treatment with NND to women with GDM would be superior to routine care, but this has never been investigated. The main aim of the randomized controlled trial Intervention with new Nordic DIet in women with GestatiOnal diabetes mellitus (iNDIGO) is to test if the NND compared with usual care will improve glucose control in women with GDM. The iNDIGO study is a randomized parallel, single-blinded, controlled trial. In total, 50 women diagnosed with GDM are recruited and randomized to receive either a NND (intervention) or usual care (control) for 14 days. Participants receive a two-week menu and provided with food bags containing ingredients for dishes and foods to be used. Primary outcome is glycemic control (specifically time in target) measured using continuous glucose monitoring. Compliance to the dietary intervention will be tested using known dietary biomarkers and adherence questionnaires. Maternal socio-demographic and clinical data, biological samples, dietary intake and physical activity will be collected at enrollment and at the end of intervention (30-32 weeks' gestation).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gestational Diabetes Mellitus

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Masking Description
Outcome is percentage of time in target of blood glucose values, measured with continuous glucose monitoring. The device will be masked for participants. Still, because the trial is a diet intervention, participants will know their group status. However, initial data reaching the Investigators will not have the code broken.
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
Women randomized to the New Nordic Diet meet the study dietician at week 30 for 1.5 hr of individual diet treatment according to the New Nordic Diet and a cognitive behavioral approach. The diet advice include evenly distributed meals over the day, foods low in fat and rich in fibre, 500 g fruit and vegetables daily, fish 2-3 times a week and keyhole foods. Participants will prepare their own food but are provided with recipes and food bags containing ingredients and foods to be consumed during the two-week intervention At gestational age 32 weeks, women meet with a dietitian and will be instructed to continue with the New Nordic Diet diet throughout pregnancy on their own.
Arm Title
Control
Arm Type
Active Comparator
Arm Description
The control women receive diet advice according to usual care.
Intervention Type
Behavioral
Intervention Name(s)
New Nordic Diet
Intervention Description
The New Nordic Diet conforms with the Nordic Nutrition Recommendations and incorporates environmental sustainability and planetary health. It includes rapeseed oil, whole grain bread, wild fish, seafood and game, potatoes, root vegetables, cabbages, Nordic fruits and berries. A two-week menu including all daily meals has been created to ensure dietary goals of the New Nordic Diet intervention: fish and shellfish intake ≥ 3 times/w (fatty fish at least once per week), ≥ 500 g fruit, berries, vegetables and legumes daily (legumes as main protein source at least twice per week), whole-grain cereal products, rapeseed oil for cooking/dressing and three table spoons of nuts and seeds per day.
Intervention Type
Other
Intervention Name(s)
Control
Intervention Description
The control women receive diet advice according to usual care, which may be a short meeting with the regular midwife or a short meeting with a dietician. From the study, they will receive a gift certificate that can be used in grocery stores.
Primary Outcome Measure Information:
Title
Time in Target at gestational week 32
Description
Percentage of time in target (TIT) range 3.5-7.8 mmol/L measured with continuous glucose monitoring
Time Frame
At week 32 of pregnancy
Secondary Outcome Measure Information:
Title
Pregnancy weight gain
Description
Weight gain during pregnancy from self-reported pre-pregnancy weight until delivery
Time Frame
Pre-pregnant weight up to delivery
Title
Incidence of pregnancy-induced hypertension
Description
Diagnosis of pregnancy-induced hypertension
Time Frame
Up to delivery
Title
Incidence of pre-eclampsia
Description
Diagnosis of pre-eclampsia
Time Frame
Up to delivery
Title
Prevalence of use of insulin/Metformin treatment
Description
Decision to put woman on medication for the gestational diabetes, such as metformin or insulin
Time Frame
Up to delivery
Title
Incidence of preterm delivery
Description
Delivery before 37 completed weeks
Time Frame
Up to 37 completed weeks
Title
Incidence of Caesarean sections
Description
Delivery by caesarean sections
Time Frame
Up to delivery
Title
Health-related quality of life
Description
Health-related quality of life, calculated from questionnaire information from RAND-36
Time Frame
Up to 1 year postpartum
Title
Incidence of LGA
Description
Large-for-gestational age born infant
Time Frame
At delivery
Title
Incidence of shoulder displacement
Description
Shoulder displacement of newborn infant
Time Frame
At delivery
Title
Apgar scores measurements
Description
Apgar scores measured at 1, 5 and 10 minutes after delivery
Time Frame
At delivery
Title
Additional measurements from continuous glucose monitoring at wk 32
Description
mean glucose, CV, SD, MAGE, % time with values >7.8 mmol/L, % time with values <3.5 mmol/L, glucose in different time periods, and AUC
Time Frame
At gestational week 32
Title
Additional measurements from continuous glucose monitoring at wk 36
Description
mean glucose, CV, SD, MAGE, % time with values >7.8 mmol/L, % time with values <3.5 mmol/L, glucose in different time periods, and AUC
Time Frame
At gestational week 36
Title
Incidence of macrosomia
Description
Diagnosis of macrosomia in newborn infant
Time Frame
At delivery
Title
Nutritional status
Description
Nutritional status (vitamins and minerals) of mother during pregnancy
Time Frame
During pregnancy
Title
Diet quality measuremen¨t
Description
Diet intake quality of mother during pregnancy
Time Frame
Up to delivery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: pregnant women with diagnosis of gestational diabetes in pregnancy wks 24-28. Exclusion Criteria: multiple pregnancies not understanding/able to read Swedish or English unwilling to follow a dietary intervention manifest diabetes
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anna Winkvist, PhD
Phone
46-31-7863728
Email
anna.winkvist@nutrition.gu.se
First Name & Middle Initial & Last Name or Official Title & Degree
Therese Karlsson, PhD
Phone
46-31-7863281
Email
therese.karlsson@gu.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anna Winkvist, PhD
Organizational Affiliation
Göteborg University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Antenatal care
City
Göteborg
ZIP/Postal Code
S-41650
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Verena Sengpiel, MD, PhD
Phone
46-31-3421000
Email
verena.sengpiel@obgyn.gu.se
Facility Name
Region Stockholm
City
Stockholm
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Elisabeth Storck Lindholm, MD, PhD
Phone
46725824652
Email
elisabeth.storck-lindholm@regionstockholm.se
Facility Name
Region Västerbotten
City
Umeå
ZIP/Postal Code
90185
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Julia Otten, MD, PhD
Phone
46703341559
Email
julia.otten@umu.se

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35158086
Citation
Karlsson T, Augustin H, Lindqvist M, Otten J, Petersson K, Storck-Lindholm E, Mogren I, Winkvist A. Effect of the New Nordic Diet compared with usual care on glucose control in gestational diabetes mellitus: Study protocol for the randomized controlled trial intervention with new Nordic DIet in women with GestatiOnal diabetes mellitus (iNDIGO). Contemp Clin Trials. 2022 Apr;115:106706. doi: 10.1016/j.cct.2022.106706. Epub 2022 Feb 12.
Results Reference
derived

Learn more about this trial

Randomized Controlled Trial Intervention With New Nordic DIet in Women With GestatiOnal Diabetes Mellitus: iNDIGO

We'll reach out to this number within 24 hrs